These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31866495)

  • 21. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.
    Bruzzaniti A; Neff L; Sanjay A; Horne WC; De Camilli P; Baron R
    Mol Biol Cell; 2005 Jul; 16(7):3301-13. PubMed ID: 15872089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
    Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
    Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration.
    Ahn H; Kim JM; Lee K; Kim H; Jeong D
    Biochem Biophys Res Commun; 2012 Feb; 418(1):144-8. PubMed ID: 22244876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin.
    Wang Q; Xie Y; Du QS; Wu XJ; Feng X; Mei L; McDonald JM; Xiong WC
    J Cell Biol; 2003 Feb; 160(4):565-75. PubMed ID: 12578912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
    Na W; Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Kang YH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
    Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
    J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PYK2 and FAK in osteoclasts.
    Xiong WC; Feng X
    Front Biosci; 2003 Sep; 8():d1219-26. PubMed ID: 12957821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of osteoclast function via Rho-Pkn3-c-Src pathways.
    Uehara S; Udagawa N; Kobayashi Y
    J Oral Biosci; 2019 Sep; 61(3):135-140. PubMed ID: 31400545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity.
    Lau KH; Wu LW; Sheng MH; Amoui M; Suhr SM; Baylink DJ
    J Cell Biochem; 2006 Apr; 97(5):940-55. PubMed ID: 16267838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts.
    Bruzzaniti A; Neff L; Sandoval A; Du L; Horne WC; Baron R
    Mol Cell Biol; 2009 Jul; 29(13):3644-56. PubMed ID: 19380485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity.
    Mizuta K; Matsubara T; Goto A; Addison WN; Nakatomi M; Matsuo K; Tada-Shigeyama Y; Yaginuma T; Honda H; Yoshioka I; Kokabu S
    BMC Cancer; 2022 Aug; 22(1):936. PubMed ID: 36038818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineral trioxide aggregate inhibits osteoclastic bone resorption.
    Hashiguchi D; Fukushima H; Yasuda H; Masuda W; Tomikawa M; Morikawa K; Maki K; Jimi E
    J Dent Res; 2011 Jul; 90(7):912-7. PubMed ID: 21531916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of c-Src kinase in the regulation of osteoclast function.
    Miyazaki T; Tanaka S; Sanjay A; Baron R
    Mod Rheumatol; 2006; 16(2):68-74. PubMed ID: 16633924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
    Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
    Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
    Lakkakorpi PT; Väänänen HK
    J Bone Miner Res; 1991 Aug; 6(8):817-26. PubMed ID: 1664645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory mechanism of osteoclast activation.
    Nakamura I; Rodan GA; Duong LT
    J Electron Microsc (Tokyo); 2003; 52(6):527-33. PubMed ID: 14756240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1.
    Morel A; Douat C; Blangy A; Vives V
    Front Physiol; 2024; 15():1342024. PubMed ID: 38312316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis.
    Cao HJ; Zheng LZ; Wang N; Wang LY; Li Y; Li D; Lai YX; Wang XL; Qin L
    Bone; 2015 May; 74():58-68. PubMed ID: 25554601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.